New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
December 11, 2012
07:04 EDTSOMX, PTXPernix Therapeutics acquires Somaxon for $25M
Pernix Therapeutics (PTX) and Somaxon Pharmaceuticals (SOMX) announced that they have entered into a definitive merger agreement for Pernix to acquire Somaxon in a stock-for-stock transaction with a total equity value of $25M. Under the terms of the agreement, which has been unanimously approved by the boards of directors of both companies, Somaxon stockholders will receive aggregate consideration equal to $25M in Pernix common stock. The number of shares of Pernix common stock to be issued to the stockholders of Somaxon will be based on the volume-weighted average price of Pernix's common stock over the 30 day period ending on the day immediately prior to the closing of the proposed merger, subject to limitations on the maximum and minimum number of shares of Pernix common stock issuable in the transaction based on a price range of $6.00-$9.00 per share.
News For PTX;SOMX From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
March 26, 2015
10:04 EDTPTXOn The Fly: Analyst Initiation Summary
Subscribe for More Information
07:30 EDTPTXDeutsche Bank to hold a conference
Pharma One-on-One Day is being held in Denver, Colorado on March 26.
March 25, 2015
18:33 EDTPTXOn The Fly: After Hours Movers
UP AFTER EARNINGS: Red Hat (RHT), up 4.6%... Five Below (FIVE), up 5.5%. ALSO HIGHER: Pernix Therapeutics (PTX), up 2.4% after being initiated with an Outperform at Oppenheimer. DOWN AFTER EARNINGS: Verint Systems (VRNT), down 2.3%... Pacific Sunwear (PSUN), down 5.9%. ALSO LOWER: Sucampo (SCMP), down 9.5% after filing to sell Class A common stock for holders... FutureFuel (FF) down 8% after "significant adverse impact" of P&G pact termination... Genesee & Wyoming (GWR), down 1.3% after lowering first quarter revenue guidance.
16:11 EDTPTXPernix Therapeutics initiated with an Outperform at Oppenheimer
Target $15.

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use